
    
      Dose administration details:

        -  Participants with a body weight <50 kg at baseline received Lubiprostone 12 mcg BID for
           12 weeks. If the dose was safe but did not show any efficacy at Week 1, dosage was
           increased to 24 mcg BID.

        -  Participants with a body weight >50 kg at baseline received Lubiprostone 24 mcg BID for
           12 weeks. If the dose was unsafe at Week 1, dosage was decreased to 12 mcg BID.
    
  